Supernus Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:SUPN) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 53.52 M44.41 M30.6 M58.53 M-61.66 M 71.88 M Cash from investing activities -77.01 M-12.64 M37.32 M-30.61 M48.71 M 42.78 M Cash from financing activities 3.08 M5.89 M-21.4 M935 K21.07 M 6.49 M Free cash flow 53.32 M44.19 M30.27 M58.08 M-61.79 M 70.75 M

新闻

TD Cowen raises Supernus Pharmaceuticals stock price target on Onapgo relaunch

수퍼너스 제약, 52주 신고가 경신…주당 57.76달러

Supernus Pharmaceuticals stock hits 52-week high at $57.76

Cantor Fitzgerald, Supernus 주식 투자의견 ’비중확대’ 유지

Cantor Fitzgerald reiterates Supernus stock Overweight on supply gains

Supernus Pharmaceuticals (SUPN) Surpasses Q4 Earnings and Revenue Estimates

Supernus Pharma Q4 실적 에상치보다 저조, 수익 예상치를 넘어

Supernus earnings missed by $0.48, revenue topped estimates

슈퍼너스, 3분기 수익성 충격 후 실적 시험대

Supernus faces earnings test after Q3 shock to profitability

Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to Decline

BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View